| Funding Opportunity ID: |
333654 |
| Opportunity Number: |
W81XWH-21-RCRP-IDA |
| Opportunity Title: |
DOD Rare Cancers Idea Development Award |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement
Grant |
| Category of Funding Activity: |
Science and Technology and other Research and Development |
| Category Explanation: |
|
| CFDA Number(s): |
12.420 |
| Eligible Applicants: |
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
|
| Agency Code: |
DOD-AMRAA |
| Agency Name: |
Department of Defense
Dept. of the Army — USAMRAA |
| Posted Date: |
May 18, 2021 |
| Close Date: |
Oct 15, 2021 |
| Last Updated Date: |
May 18, 2021 |
| Award Ceiling: |
$0 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
$8,400,000 |
| Expected Number of Awards: |
15 |
| Description: |
The FY21 RCRP Idea Development Award mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from rare cancers. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.Preliminary data with disease-specific rationale (may include correlatives in existing trials) to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of the proposed rare cancer type(s)/subtype(s) under study. |
| Version: |
1 |
